AI assistant
Edwards Lifesciences Corp — Director's Dealing 2021
Aug 4, 2021
30042_dirs_2021-08-03_ad9f6039-6c3b-43dd-8cdb-e2f107c07a99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-08-03
Reporting Person: MUSSALLEM MICHAEL A (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-03 | Common Stock | M | 45050.0000 | $21.7600 | Acquired | 233051.8200 | Direct |
| 2021-08-03 | Common Stock | G | 12500.0000 | $0.0000 | Disposed | 220551.8200 | Direct |
| 2021-08-03 | Common Stock | S | 14257.0000 | $113.8000 | Disposed | 206294.8200 | Direct |
| 2021-08-03 | Common Stock | S | 18293.0000 | $114.4100 | Disposed | 188001.8200 | Direct |
| 2021-08-03 | Common Stock | G | 12500.0000 | $0.0000 | Acquired | 3185287.0000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-03 | Employee Stock Option (Right to Acquire) | $21.7600 | M | 45050.0000 | Disposed | 2022-05-13 | Common Stock (45050.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 371728.8872 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.
F2: This transaction was executed in multiple trades at prices ranging from $113.1450 to $114.1400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $114.1500 to $114.7100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4: Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.